| |
| |
|
| Insider
Information: |
Patel Sanjiv |
| Relationship: |
President and CEO, Dir... |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
764,022 |
|
|
Indirect Shares
|
1,361,903 |
|
|
| Direct
Value |
$5,210,630 |
|
|
|
Indirect Value
|
$9,288,178 |
|
|
| Total
Shares |
2,125,925 |
|
|
| Total
Value |
$14,498,809 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Relay Therapeutics, Inc. |
RLAY |
President and CEO, Dir... |
2024-01-16 |
764,022 |
2024-01-16 |
1,361,903 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
43 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RLAY |
Relay Therapeutics, Inc. |
President and CEOOfficer |
• • – |
2020-07-15 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
378,082 |
|
- |
|
| RLAY |
Relay Therapeutics, Inc. |
President and CEOOfficer |
• • – |
2020-07-15 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
957,349 |
|
- |
|
| RLAY |
Relay Therapeutics, Inc. |
President and CEO |
• • – |
2020-07-20 |
4 |
B |
$20.00 |
$500,000 |
D/D |
25,000 |
403,082 |
2.81 |
% |
|
| RLAY |
Relay Therapeutics, Inc. |
President and CEO |
• • – |
2021-02-16 |
4 |
GD |
$0.00 |
$0 |
D/D |
150,000 |
253,082 |
0 |
- |
|
| RLAY |
Relay Therapeutics, Inc. |
President and CEO |
• • – |
2021-02-16 |
4 |
GA |
$0.00 |
$0 |
I/I |
150,000 |
674,548 |
0 |
- |
|
| RLAY |
Relay Therapeutics, Inc. |
President and CEO |
• • – |
2021-12-31 |
4 |
A |
$26.10 |
$17,174 |
D/D |
658 |
253,740 |
0 |
- |
|
| RLAY |
Relay Therapeutics, Inc. |
President and CEO |
• • – |
2022-04-12 |
4 |
OE |
$4.12 |
$115,360 |
D/D |
28,000 |
281,740 |
0 |
- |
|
| RLAY |
Relay Therapeutics, Inc. |
President and CEO |
• • – |
2022-04-12 |
4 |
AS |
$31.80 |
$890,400 |
D/D |
(28,000) |
253,740 |
0 |
% |
|
| RLAY |
Relay Therapeutics, Inc. |
President and CEO |
• • – |
2022-04-13 |
4 |
OE |
$4.12 |
$128,240 |
D/D |
28,000 |
267,740 |
0 |
- |
|
| RLAY |
Relay Therapeutics, Inc. |
President and CEO |
• • – |
2022-04-13 |
4 |
AS |
$31.94 |
$894,600 |
D/D |
(28,000) |
253,740 |
0 |
% |
|
| RLAY |
Relay Therapeutics, Inc. |
President and CEO |
• • – |
2022-04-14 |
4 |
AS |
$30.51 |
$854,280 |
D/D |
(28,000) |
253,740 |
0 |
% |
|
| RLAY |
Relay Therapeutics, Inc. |
President and CEO |
• • – |
2022-04-14 |
4 |
OE |
$4.12 |
$128,240 |
D/D |
28,000 |
267,740 |
0 |
- |
|
| RLAY |
Relay Therapeutics, Inc. |
President and CEO |
• • – |
2022-06-30 |
4 |
A |
$14.24 |
$11,591 |
D/D |
814 |
254,554 |
0 |
- |
|
| RLAY |
Relay Therapeutics, Inc. |
President and CEO |
• • – |
2022-09-13 |
4 |
OE |
$4.12 |
$57,680 |
D/D |
14,000 |
268,554 |
0 |
- |
|
| RLAY |
Relay Therapeutics, Inc. |
President and CEO |
• • – |
2022-09-13 |
4 |
AS |
$25.45 |
$356,300 |
D/D |
(14,000) |
254,554 |
0 |
% |
|
| RLAY |
Relay Therapeutics, Inc. |
President and CEO |
• • – |
2022-09-14 |
4 |
AS |
$23.47 |
$328,580 |
D/D |
(14,000) |
254,554 |
0 |
% |
|
| RLAY |
Relay Therapeutics, Inc. |
President and CEO |
• • – |
2022-09-14 |
4 |
OE |
$4.12 |
$57,680 |
D/D |
14,000 |
268,554 |
0 |
- |
|
| RLAY |
Relay Therapeutics, Inc. |
President and CEO |
• • – |
2022-09-15 |
4 |
OE |
$4.12 |
$57,680 |
D/D |
14,000 |
268,554 |
0 |
- |
|
| RLAY |
Relay Therapeutics, Inc. |
President and CEO |
• • – |
2022-09-15 |
4 |
AS |
$23.80 |
$333,200 |
D/D |
(14,000) |
254,554 |
0 |
% |
|
| RLAY |
Relay Therapeutics, Inc. |
President and CEO |
• • – |
2022-10-11 |
4 |
OE |
$4.12 |
$57,680 |
D/D |
14,000 |
268,554 |
0 |
- |
|
| RLAY |
Relay Therapeutics, Inc. |
President and CEO |
• • – |
2022-10-11 |
4 |
AS |
$21.36 |
$299,040 |
D/D |
(14,000) |
254,554 |
0 |
% |
|
| RLAY |
Relay Therapeutics, Inc. |
President and CEO |
• • – |
2022-10-12 |
4 |
AS |
$21.18 |
$296,520 |
D/D |
(14,000) |
254,554 |
0 |
% |
|
| RLAY |
Relay Therapeutics, Inc. |
President and CEO |
• • – |
2022-10-12 |
4 |
OE |
$4.12 |
$57,680 |
D/D |
14,000 |
268,554 |
0 |
- |
|
| RLAY |
Relay Therapeutics, Inc. |
President and CEO |
• • – |
2022-10-13 |
4 |
OE |
$4.12 |
$57,680 |
D/D |
14,000 |
268,554 |
0 |
- |
|
| RLAY |
Relay Therapeutics, Inc. |
President and CEO |
• • – |
2022-10-13 |
4 |
AS |
$20.58 |
$288,120 |
D/D |
(14,000) |
254,554 |
0 |
% |
|
43 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
